Updates on Erdheim-Chester disease

Ismail Elbaz Younes, Austin Ellis, Xiaohui Zhang

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Erdheim-Chester disease (ECD) is a non-Langerhans cell histiocytosis characterized by multisystemic proliferation of histiocytes in a background of fibrosis and inflammation. Patients with ECD have diverse clinical manifestations with multiple organ or system involvement, and pathognomonic radiographical findings such as symmetric cortical osteosclerosis of the diaphysis and metaphysis of the long bones in the lower extremities, “coated aorta”, and “hairy kidney”. Histopathologically, lesions are composed of epithelioid/foamy histiocytes with fibrosis and admixed inflammatory cells. Most cases of ECD harbor an activating mutation in the MAPK pathway, most commonly BRAF V600E mutation. Prognosis has improved with the use of multiple treatment modalities and the advent of novel targeted therapies.

Original languageEnglish (US)
Article number300636
JournalHuman Pathology Reports
StatePublished - Jun 2022
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2022 The Authors


  • Erdheim-Chester disease
  • Histiocytic/dendritic neoplasm
  • Histiocytosis


Dive into the research topics of 'Updates on Erdheim-Chester disease'. Together they form a unique fingerprint.

Cite this